ABOUT WCG

WCG is the world's leading strategic partner to sponsors, CROs, institutions, and sites providing agile, knowledge based services that proactively optimize clinical development programs. For more information, visit www.wcgclinical.com.

FEATURED PRODUCTS

Patient Engagement Patient Engagement

WCG’s end-to-end patient recruitment solution connects patients to clinical trials, enhances site resources and capabilities, and improves study data quality and endpoints. On average, we are helping our clients achieve a 33% acceleration in their enrollment timelines.

Site Activation Site Activation

The right sites can make all the difference. At WCG, we help clients to identify, select, and engage the highest performing investigators for their clinical research trials.

Ethical & Regulatory Review Ethical & Regulatory Review

For 50 years, WIRB-Copernicus Group has stood as the gold standard of ethical and regulatory human research oversight, with more years of IRB and IBC experience and more deep, trusted relationships with sponsors, CROs, institutions, and investigators.

Product Safety Product Safety

WCG offers the only global safety reporting solution and PV services that have been demonstrated to increase compliance and improve patient safety, while reducing cost and streamlining operations.

CONTACT INFORMATION

WCG

212 Carnegie Center

Princeton, NJ 08540

UNITED STATES

Phone: 609-945-0120

Contact: Lauren Ozmore

FEATURED ARTICLES

  • Reducing Placebo Response & Measurement Error In Clinical Trials
    Reducing Placebo Response & Measurement Error In Clinical Trials

    In this on-demand webcast, WCG experts Dr. Nathaniel Katz and Dr. Mark Opler illustrate why human error—including inaccurate symptom reporting—is driving placebo response and how proven, evidence-based interventions can be used to increase the overall chance of trial success. Hear their perspectives.

  • How Calibrated Are Your Trial-Measurement Tools?
    How Calibrated Are Your Trial-Measurement Tools?

    Every person participating in a clinical trial creates inherent variability in the way they perform. A patient’s ability to report their symptoms accurately will impact trial data, as will a site staff’s verbal and non-verbal communication cues. But what if you could train people to reduce measurement error—and even decrease the placebo response? Read the article to find out how.

  • WCG Introduces Velos eResearch eXpress

    The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division introduces Velos eResearch eXpress™, an out-of-the-box, cloud-based solution that enables clinical research sites to centralize and manage their research activities on a single, automated technology platform.

  • Independent Research Sites: Three Key Performance Metrics To Help You Increase Your Study Pipeline
    Independent Research Sites: Three Key Performance Metrics To Help You Increase Your Study Pipeline

    This article provides practical solutions for overcoming the biggest challenges independent clinical research sites face in data collection. Further, it highlights three key metrics that will help sites improve performance and drive success.

  • To Mitigate Placebo Response, Test, Train And Control Expectations
    To Mitigate Placebo Response, Test, Train And Control Expectations

    The placebo effect. It’s the curse of clinical trials across indications, but it’s a particularly thorny issue for pain researchers. In fact, along with the inability of many patients to accurately report symptoms, it may be the main challenge facing analgesic trials. Left unaddressed, these issues have contributed to the failure of many clinical trials.

  • Identify And Rectify Data Problems Before It's Too Late
    Identify And Rectify Data Problems Before It's Too Late

    In this blog post we discuss how central surveillance using statistical process control (SPC) and other analytical techniques-- combined with expert human analysis--maximizes assay and endpoint sensitivity, allowing sponsors to meet scientific and regulatory expectations for quality data in clinical trials.

  • What You Don’t Know About Patient Recruitment Can Impede The Success Of Your Trial
    What You Don’t Know About Patient Recruitment Can Impede The Success Of Your Trial

    Recruitment is one of the things sites and sponsors just do. Everyone thinks they know what it means. But it’s so much more complicated than they imagine.

  • Your 5 Questions About Enrollment Assistants Answered
    Your 5 Questions About Enrollment Assistants Answered

    Enrollment assistants ease site burden and increase patient engagement. Following are answers to five common questions about the use of this on-the-ground recruitment support.

  • Lessons Learned From 600+ Expert Committee Members
    Lessons Learned From 600+ Expert Committee Members

    Sponsors and CROs make increasing use of expert committees. Learn from members themselves on what it takes to have successful expert committee.

  • WCG Acquires PharmaSeek, LLC

    The WIRB-Copernicus Group’s (WCG) Clinical Services Division announced the acquisition of PharmaSeek, LLC, including its wholly-owned subsidiaries PFS Clinical and PatientWise, leading providers of turn-key administrative, consulting, patient recruitment and training solutions for clinical research sites.

  • Ask The IRB Experts
    Ask The IRB Experts

    Clinical research is complicated.  At WCG, we frequently get questions about the ethical conduct of research from clinical team members at biopharma companies and study sites. We know that for many of the questions we get, the person asking is not the only one struggling with that issue. Read the questions your peers are asking – and if you don’t see yours, submit one of your own.

  • Not Like Everyone Else: Unique Challenges For Small And Emerging Biopharma Companies
    Not Like Everyone Else: Unique Challenges For Small And Emerging Biopharma Companies

    Small and emerging biopharma companies are conducting almost 50% of the clinical trials in the United States today. Unlike “big pharma”, small companies are usually working with lean teams, limited resources, and minimal infrastructure. In this paper, we explore some of the unique challenges for clinical development teams, and solutions that can reduce the pressure on teams and timelines.

  • Compensating Participants In Clinical Research: Current Thinking
    Compensating Participants In Clinical Research: Current Thinking

    New research on how people make decisions about research participation, and new approaches to the question of payments and compensation to participants, bring a new perspective; are payments to participants actually too low? This paper explores this question, and whether we should, in fact, worry much less about restricting compensation for research participants.

  • Removing Barriers: Reimbursement And Compensation For Participation In Oncology Clinical Trials
    Removing Barriers: Reimbursement And Compensation For Participation In Oncology Clinical Trials

    Approximately 20% of cancer clinical trials will never be completed, because they fail to enroll enough participants to be able to answer the research question. Read this white paper to learn the impact that participant payments may play on clinical trial recruitment.

  • WCG Expands Its Research Site Executive Team, Global Research Network

    The WIRB-Copernicus Group® (WCG™) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network™ (GRN) of investigative sites. WCG is the leader in supporting clinical research sites in their critically important work of conducting clinical trials.

  • WCG Announces The Acquisition Of Analgesic Solutions, LLC

    The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in which pain is an indicator of an underlying condition.

  • WCG Introduces A Transformational Solution For Clinical Research Sites

    WIRB-Copernicus Group® (WCG™) introduces WCG SiteReady™, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent research sites. WCG’s newest offering helps researchers to optimize their performance, gain a competitive edge, and attract more opportunities for externally-funded clinical trials.

  • Addressing Suggestibility As A Psychological Phenomenon In Clinical Trials
    Addressing Suggestibility As A Psychological Phenomenon In Clinical Trials

    How can researchers identify participants’ overall level of suggestibility and then focus on the minimization of this characteristic to solve the issue of suggestibility in clinical trial?

  • Genetic Counselors - Helping Researchers Brace For The Silver Tsunami Of CNS Disorders
    Genetic Counselors - Helping Researchers Brace For The Silver Tsunami Of CNS Disorders

    Genetic testing is making it easier to identify patients for clinical trials. However, genetic testing in the context of clinical trials raises raise important ethical issues, including ones related to informed consent and disclosure of results. Genetic counselors can play a crucial role in helping sponsors address these operational and ethical issues, making trials more efficient, more patient-centered and, ultimately, more successful.

  • Invert To Convert: Rethinking Patient Recruitment And Enrollment Strategies
    Invert To Convert: Rethinking Patient Recruitment And Enrollment Strategies

    Overall, the landscape of patient recruitment and enrollment have become highly specialized and data-driven. They demand a specialized, data-driven approach that nurtures potential participants and delivers bottom-line results, quickly and within budget. Read how an Enrollment Assistant can reduce the site’s workload, accelerate enrollment and make the entire recruitment process more efficient.